NY settles Pharmacia pricing case for $2.5M; Merck KGaA now expects faster growth;

@FiercePharma: AstraZeneca plots $150M facility in Russia. Story | Follow @FiercePharma

> New York Attorney General Eric Schneiderman announced a $2.5 million settlement in a pricing-inflation case against Pharmacia, with the recovered funds going to the state's Medicaid program and its drug program for the elderly. Report

> Merck KGaA raised the prospect of faster growth in operating income this year than analysts had expected, citing growth at its new lab gear unit Millipore and lower costs. Story

> Sanofi Aventis plans to buy branded generics and over-the-counter (OTC) consumer healthcare brands in India as part of its strategy to scale up sales from new avenues, a company executive said. News

> The European Parliament has voted in favor of the Falsified Medicines Directive to help stop the flow of counterfeit medicines in Europe. Item

> Medco Health Solutions posted a roughly 11 percent rise in fourth-quarter profit to $378.5 million as the U.S. pharmacy benefit manager increased its mail-order prescriptions of generic drugs. Article

> Ranbaxy Laboratories, India's top drugmaker by sales, swung to a fourth-quarter loss as operating expenses rose from a year earlier. Report

> The National Institute for Health and Clinical Excellence is seeking opinion on its new blood pressure guidelines, which have undergone a major rehaul in a bid to boost the accuracy of diagnosis and save the National Health Service some cash. Item

Biotech News

@FierceBiotech: Fast Company highlights 10 top innovators in biotech. Article | Follow @FierceBiotech

@JohnCFierce: FDA plans to release new biosimilar rules "very soon." Report | Follow @JohnCFierce 

> Forest Labs swallows Clinical Data pill in $1.2B buyout. Story 

> Delcath in a tailspin after FDA punts back NDA. Item

> FDA chief vows fast delivery of new biosimilar rules. Report

> Gilead nabs Calistoga with $600M buyout deal. News

Biotech Research News

> Scripps taps Berkeley chemist to replace Lerner at the helm. Item 

> Drugs pierce blood-brain barrier with 'delivery vector.' Story

> Scientists ID and engineer leukemia-fighting protein. Article

> New 'microworms' could monitor, treat patients. Report

> Singapore infuses another $1B into R&D fund. Story 

> Melanoma-seeking nanoparticle enters testing. Item 

Biotech IT News

> In Canada, a trial data security charade. News 

> Pharma will breathe easy when patient trumps drug. Article

> Virtual studies target antibiotic dosing. News 

> Mobile apps push FDA device boundary. Report 

Manufacturing News

> CMO Troy achieves quest for brand ownership. Article

> Genzyme's bio-ops savvy a job-saver. News 

> Ethicon joins J&J recall train. Article 

> Post-blockbuster era drives ops reform. Story

> Pfizer quantifies green gains. Item

And Finally... A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, PricewaterhouseCoopers says. Report